
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.
The CPRD bibliography is updated on a monthly basis (last updated 4 December 2019) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 193 pages)
“A study on the epidemiology of tinnitus in the United Kingdom”, Clin Epidemiol, vol. 11, pp. 855-871, 2019.
, “Tamoxifen and cataracts: a null association”, Breast Cancer Res Treat, vol. 87, pp. 189-96, 2004.
, “Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina”, Cancer, vol. 103, pp. 1114-21, 2005.
, “Trends in incidence and medical resource utilisation in patients with chronic lymphocytic leukaemia: insights from the UK Clinical Practice Research Datalink (CPRD)”, Ann Hematol, vol. 94, pp. 421-9, 2015.
, “Type II diabetes mellitus and incident osteoarthritis of the hand: a population-based case-control analysis”, Osteoarthritis Cartilage, vol. 24, pp. 1535-40, 2016.
, “Urinary tract infections and estrogen use in older women”, J Am Geriatr Soc, vol. 40, pp. 817-20, 1992.
, “Use of acid-suppressive drugs in pregnancy and the risk of childhood asthma: bidirectional crossover study using the general practice research database”, Drug Saf, vol. 36, pp. 1097-104, 2013.
, “Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis”, Am J Gastroenterol, vol. 107, pp. 620-6, 2012.
, “Use of anti-malarial drugs and the risk of developing eye disorders”, Travel Med Infect Dis, vol. 12, pp. 40-7, 2014.
, “Use of beta-blockers and risk of fractures”, Jama, vol. 292, pp. 1326-32, 2004.
, “Use of cardiac glycosides and risk of glioma”, J Neurooncol, vol. 127, pp. 321-8, 2016.
, “Use of depot medroxyprogesterone acetate and fracture risk”, J Clin Endocrinol Metab, vol. 95, pp. 4909-16, 2010.
, “Use of diuretics and risk of incident gout: a population-based case-control study”, Arthritis Rheumatol, vol. 66, pp. 185-96, 2014.
, “Use of metformin and the risk of ovarian cancer: a case-control analysis”, Gynecol Oncol, vol. 123, pp. 200-4, 2011.
, “Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis”, Cancer Epidemiol Biomarkers Prev, vol. 21, pp. 280-6, 2012.
, “Use of Selective Cyclooxygenase-2 Inhibitors, Other Analgesics, and Risk of Glioma”, PLoS One, vol. 11, p. e0149293, 2016.
, “Use of statins and the risk of Parkinson's disease: a retrospective case-control study in the UK”, Drug Saf, vol. 31, pp. 399-407, 2008.
, “Use of thiazolidinediones and fracture risk”, Arch Intern Med, vol. 168, pp. 820-5, 2008.
, , “Validation of autism spectrum disorder diagnoses recorded in the Clinical Practice Research Datalink, 1990-2014”, Clin Epidemiol, vol. 9, pp. 475-482, 2017.
, “Validation of information recorded on general practitioner based computerised data resource in the United Kingdom”, Bmj, vol. 302, pp. 766-8, 1991.
, “Validation of Stevens-Johnson syndrome or toxic epidermal necrolysis diagnoses in the Clinical Practice Research Datalink”, Pharmacoepidemiol Drug Saf, vol. 26, pp. 429-436, 2017.
, “Validity of the general practice research database”, Pharmacotherapy, vol. 23, pp. 686-9, 2003.
, “Weight change and blood glucose concentration as markers for pancreatic cancer in subjects with new-onset diabetes mellitus: A matched case-control study”, Pancreatology, 2019.
, “Who receives lipid-lowering drugs: the effects of comorbidities and patient characteristics on treatment initiation”, Br J Clin Pharmacol, vol. 55, pp. 288-98, 2003.
,